Collaborative Neuroscience Network is Other Pharmaceuticals and Biotechnology in United States that focus on health conditions business. Founded in 2000. They cover business area such as provider, clinical research service, clinical trial, new medication, treatment, various therapeutic area, neurology, psychiatry, general health condition.
Other Pharmaceuticals and Biotechnology
2000
( 24 years old in 2024 )
Health Conditions
-
12772 Valley View Street
Suite 3
Garden Grove, CA 92845
United States
Private
providerclinical research serviceclinical trialnew medicationtreatmentvarious therapeutic areaneurologypsychiatrygeneral health condition
* We use standard office opening hours in near Collaborative Neuroscience Network's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Collaborative Neuroscience Network is Other Pharmaceuticals and Biotechnology business from United States that founded in 2000 (24 years old in 2024), Collaborative Neuroscience Network business is focusing on Health Conditions.
Collaborative Neuroscience Network headquarter office and corporate office address is located in 12772 Valley View Street Suite 3 Garden Grove, CA 92845 United States.
Collaborative Neuroscience Network was founded in United States.
In 2024, Collaborative Neuroscience Network is currently focus on health conditions sector.
Above is snippet of Google Trends for "health conditions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Collaborative Neuroscience Network, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
